Phase 3 trial of three thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant-eligible.
Ann Hematol
; 95(2): 271-8, 2016 Jan.
Article
in En
| MEDLINE
| ID: mdl-26518211
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thalidomide
/
Antineoplastic Combined Chemotherapy Protocols
/
Hematopoietic Stem Cell Transplantation
/
Multiple Myeloma
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Guideline
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
Ann Hematol
Journal subject:
HEMATOLOGIA
Year:
2016
Document type:
Article
Affiliation country:
Brazil